SCHEMBL29372602

SCHEMBL29372602

COc1ccc2sc3ccccc3c(=O)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 1.00
NPC1 O15118 5/20 1.00
RAB9A P51151 5/20 1.00
KDM4E B2RXH2 5/20 1.00
MAPT P10636 5/20 1.00
TDP1 Q9NUW8 2/20 1.00
L3MBTL1 Q9Y468 2/20 1.00
MAOA P21397 3/20 0.54
ABCG2 Q9UNQ0 1/20 0.54
HPGD P15428 6/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
CYP1A2 P05177 2/20 0.54
HSD17B10 Q99714 2/20 0.54
TP53 P04637 1/20 0.54
ALOX15 P16050 1/20 0.54
TSHR P16473 1/20 0.54
NFKB1 P19838 1/20 0.54
MAPK1 P28482 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1880565 1.00 ALDH1A1 (1.00) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL29359913 1.00 ALDH1A1 (1.00) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL30120715 0.91 KDM4E (0.83) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL21112920 0.91 MAPT (0.83) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL26983883 0.91 KDM4E (0.83) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL31037131 0.90 ALDH1A1 (0.82) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL30612325 0.90 ALDH1A1 (0.82) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL4481328 0.90 ALDH1A1 (0.82) ALDH1A1NPC1RAB9AKDM4EMAPT
Propiolactone SCHEMBL6691395 0.89 NPC1 (0.79) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL8964851 0.86 ALDH1A1 (0.75) ALDH1A1NPC1RAB9AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108289922-B Therapeutic methods and compositions for treating non-small cell lung cancer 友杏生技医药股份有限公司 2022-02-08 CN disclosed